31 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... screen within 1 year ... 3 years • Co-testing ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... mg per day) >1 year ... Meningoencephalitis #IDSA ... #Treatment #management ... #cryptococcus #HIVAIDS
Yergason's Test on Physical Exam
Yergason's test for biceps tendon pathology testing stability of the tendon within
Yergason's Test ... Exam Yergason's test ... tendon pathology testing ... pathology and/or SLAP tear ... clinical #video #msk
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Preventing and Treating ... Penicilliosis #IDSA ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS
Group A Strep Pharyngitis, also known as  Strep Throat. 

In addition to symptomatic presentation, a
antigen detection test ... prescribed one of the treatment ... recommended by IDSA ... That's because this test ... penicillin allergy testing
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Preventing and Treating ... Disease Note: Treatment ... Trypanosomiasis #IDSA ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Preventing and Treating ... Enteric #Bacterial #IDSA ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... for Treating Mucosal ... for effective treatment ... candida #mucosal #IDSA ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... for Treating Visceral ... every 21 days Treating ... Leishmaniasis #Prevention #Treatment ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... for Treating Isospora ... IsosporaBelli #IDSA ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS